Bladder Cancer | Medscape

Bladder Cancer News

GUCS Long-Term Benefits With Chemoradiation for Bladder Cancer An analysis of 6 studies shows that bladder preservation therapy with chemotherapy and high-dose radiation is a viable option for patients with less advanced and less bulky disease.
Medscape Medical News, February 6, 2012
Vandetanib No Aid to Docetaxel in Pretreated Urothelial Cancer In platinum-pretreated patients with metastatic urothelial cancer, researchers tried to improve outcomes by adding vandetanib to docetaxel, but the results were disappointing.
Reuters Health Information, January 27, 2012

Pioglitazone Not Strongly Tied to Bladder Cancer in Asians
Reuters Health Information, January 26, 2012
Arsenic Cancer Risk Still High Decades Later
Reuters Health Information, January 26, 2012
RSNA MRI Can Identify Metastatic Lymph Nodes
Medscape Medical News, November 29, 2011
ASCP UroVysion Can Bolster Urine Cytology Sensitivity
Medscape Medical News, October 25, 2011

Chemoradiotherapy Reduces Recurrence of Bladder Cancer Prof. Nick James reports on his study which showed that combining fluorouracil and mitomycin C as radiosensitizers reduces locoregional recurrence of bladder cancer by 33%.
ecancer, April 11, 2011
Cochrane Review Abstracts A Cochrane Review Abstract: Evidence Based Medicine reviews based primarily on meta-analysis of controlled clinical trials.
July 1, 2007